Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SK pseudogene 156 (RN7SKP156) is classified as a pseudogene derived from the parent gene RN7SK, which encodes a small nuclear RNA fundamental for regulation of the transcription elongation factor P-TEFb in metazoans[1][3][5]. Pseudogenes such as RN7SKP156 occur through genomic duplication or retrotransposition events and are typically nonfunctional, meaning they are not transcribed into active RNA or protein and do not contribute known biological or disease roles. Unlike the functional RN7SK RNA, which is involved in the control of transcription elongation, RN7SKP156 does not encode a functional product and is not considered a biological or therapeutic target[3]. If you require structured information, this pseudogene should be flagged as non-target and non-functional[3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RN7SK pseudogene 156 (RN7SKP156).